Can-Fite BioPharma vs Rallybio
CANF and RLYB side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CANF and RLYB compare
Rallybio grew revenue faster over the last twelve months (−35.6% versus −39.9% for Can-Fite BioPharma).
Rallybio keeps more of each dollar of sales as profit, with a net margin of 6177% compared with −2427% at Can-Fite BioPharma.
Rallybio scores higher on the StockData Score (10 against 1 for Can-Fite BioPharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CANF | RLYB |
|---|---|---|
| Size and price | ||
| Market cap | – | $84.3M |
| Share price | $1.49 | $15.65 |
| Change, 1 year | −81.2% | 177% |
| Change, 5 years | −99.4% | −85.6% |
| Beta (5Y) | 1.10 | 0.63 |
| Employees | 5 | 14 |
| StockData Score | ||
| Total score | 1 | 10 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 2 (better) |
| Health score | 1 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 3.4× |
| P/S | – | 194× |
| P/B | – | 0.9× |
| Growth | ||
| Revenue growth (TTM) | −39.9% | −35.6% (better) |
| Revenue growth, 5Y average | −11.9% | – |
| Profitability | ||
| Operating margin | −2457% (better) | −5581% |
| Net margin | −2427% | 6177% (better) |
| FCF margin | −2210% | – |
| Return on equity | −217% | 34.5% (better) |
| Return on invested capital | – | −718% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −35.0× | – |
| Current ratio | 3.60 | 28.87 (better) |
| Altman Z-score | – | 11.77 |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 1.9% | – |
| Held by insiders | 0.00% | 72.6% |
| Insider net buying, 12 months | – | $4.2M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 2.6% |
Go deeper
- CANF stock overview
- CANF income statement
- CANF valuation and score
- RLYB stock overview
- RLYB income statement
- RLYB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.